Seward Introduces Additional Sample Handling Alternatives to Pipette Tips
Seward Ltd has expanded its range of Simplette pipetting straws to fit a wider variety of variable-volume pipette handsets. Providing an accurate and economical sample handling alternative to pipette tips and graduated pipettes, disposable Simplettes are designed specifically to transfer prepared samples from the bottom of a Stomacher bag without risk of cross contamination.
Now available with a narrower internal diameter of 3.6–3.7 mm, as well as 4.1–4.2 mm, Simplette straws will fit pipette handsets from a number of companies, including Barky and Socorex. Pipetting volumes of between 0.1 to 2 mL, Simplettes are also available in both 170 and 250-mm lengths, which means that a homogenised sample can be removed from the Stomacher bag for microbiological inoculations without risk of cross contamination, as the handset has no contact with the bag.
Irradiated sterile, Simplettes are available in a variety of quantities, either in bulk boxes of 1000 and 2000, or in convenient sachets of 25 or 50. The new narrower gauge Simplettes are available in quantities of 25 in a re-sealable clear sachet, making it easy to check the number of straws left for use.
“Following feedback from our customers, we have expanded our range of Simplette straws to better meet their sample handling requirements,” commented Stuart Ray, Seward’s Technical Director. “We are always keen to address customer requests; for example, we have also designed a Simplette with the dairy industry in mind, this is blue so it can be easily spotted when used for milk pipetting applications.”
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.